Atlas Trials

Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma

Clinical trial NCT02834546 · COMPLETED

Trial details

NCT number
NCT02834546
Sponsor
University Hospital, Bordeaux
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatocellular Carcinoma (HCC)
Start date
2017-07-25
Primary completion
2019-03-15
Enrollment
143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.